| scholarly article | Q13442814 |
| P2093 | author name string | G Trinchieri | |
| F Sherman | |||
| S C Clark | |||
| B Perussia | |||
| I Anegón | |||
| M C Cuturi | |||
| R Loudon | |||
| P2860 | cites work | Isolation and DNA sequence of a full-length cDNA clone for human X chromosome-encoded phosphoglycerate kinase | Q24602089 |
| Human CSF-1: molecular cloning and expression of 4-kb cDNA encoding the human urinary protein | Q28299182 | ||
| Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3. | Q34180710 | ||
| Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1 | Q34333698 | ||
| Identification of three accessory cell populations in human bone marrow with erythroid burst-promoting properties | Q34625556 | ||
| Pluripoietin alpha: a second human hematopoietic colony-stimulating factor produced by the human bladder carcinoma cell line 5637. | Q35599527 | ||
| Human neutrophil Fc gamma receptor distribution and structure | Q36296665 | ||
| Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity | Q36348121 | ||
| Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon | Q36351193 | ||
| Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells | Q36354528 | ||
| Mechanisms of lymphocytic choriomeningitis virus-induced hemopoietic dysfunction | Q36864996 | ||
| Regulation of hematopoiesis by T lymphocytes and natural killer cells | Q39483678 | ||
| Do Natural Killer Cells Engage in Regulated Reactions Against Self to Ensure Homeostasis? | Q39785852 | ||
| Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts | Q40828092 | ||
| In vivo function of natural killer cells as regulators of myeloid precursor cells in the spleen | Q41422396 | ||
| Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity | Q41482089 | ||
| Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes | Q41845609 | ||
| Gamma interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation | Q41921376 | ||
| Generation of natural killer cells: an autonomous function of the bone marrow | Q42102149 | ||
| Response of resting human peripheral blood natural killer cells to interleukin 2. | Q42153962 | ||
| Monoclonal antibodies that detect differentiation surface antigens on human myelomonocytic cells. | Q42800922 | ||
| Identification and characterization of a pore-forming protein of human peripheral blood natural killer cells | Q42938599 | ||
| Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor | Q43819326 | ||
| Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines | Q43987907 | ||
| Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines | Q44577659 | ||
| In vitro regulation of human hematopoiesis by natural killer cells: analysis at a clonal level | Q44843699 | ||
| Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins | Q48378915 | ||
| Terminal differentiation surface antigens of myelomonocytic cells are expressed in human promyelocytic leukemia cells (HL60) treated with chemical inducers. | Q53569714 | ||
| Cellular regulation of human megakaryocytopoiesis in vitro | Q68800811 | ||
| Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells | Q68809492 | ||
| Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells | Q68821123 | ||
| Selective generation of erythroid burst-promoting activity by recombinant interleukin 2-stimulated human T lymphocytes and natural killer cells | Q69823383 | ||
| Large granular lymphocytes have a promoting activity on human peripheral blood erythroid burst-forming units | Q69832521 | ||
| Modulation of in vitro myelopoiesis by LGL: different effects on early and late progenitor cells | Q69996970 | ||
| Stimulation of neutrophils by tumor necrosis factor | Q70138077 | ||
| Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1 | Q70288762 | ||
| Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor | Q70322634 | ||
| Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells | Q70373686 | ||
| Characterization of an antigen expressed by human natural killer cells | Q70903442 | ||
| Induction of proliferation of purified human myeloid progenitor cells: a rapid assay for granulocyte colony-stimulating factors | Q71004235 | ||
| Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. | Q71689181 | ||
| Inhibition of in vitro granulopoiesis by autologous allogeneic human NK cells | Q72668078 | ||
| Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor | Q72715109 | ||
| The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies | Q72815618 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 569-583 | |
| P577 | publication date | 1989-02-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Production of hematopoietic colony-stimulating factors by human natural killer cells | |
| P478 | volume | 169 |
| Q36403580 | A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells |
| Q50876710 | A role for natural killer cells in the immunopathogenesis of multiple sclerosis. |
| Q45112825 | Activated CD3- CD16+ natural killer cells express a subset of the lymphokine genes induced in activated alpha beta + and gamma delta + T cells. |
| Q68084399 | Activated but not resting T cells or thymocytes express colony-stimulating factor 1 mRNA without co-expressing c-fms mRNA |
| Q67686172 | Activation of CD16+ effector cells by rheumatoid factor complex. Role of natural killer cells in rheumatoid arthritis |
| Q47683702 | Altered coexpression of lectin-like receptors CD94 and CD161 on NK and T cells in HIV patients |
| Q72876731 | Alveolar macrophage inhibition of lung-associated NK activity: involvement of prostaglandins and transforming growth factor-beta 1 |
| Q46679645 | Analysis of individual natural killer cell responses |
| Q101053392 | Antigens of Mycobacterium tuberculosis Stimulate CXCR6+ Natural Killer Cells |
| Q41373731 | Arousal and inhibition of human NK cells |
| Q29619728 | Biology of natural killer cells |
| Q46056808 | Bone marrow cell modulation and inhibition of myelopoiesis by large granular lymphocytes and natural killer cells |
| Q40517634 | CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses |
| Q80203737 | CD40 ligation during dendritic cell maturation reduces cell death and prevents interleukin-10-induced regression to macrophage-like monocytes |
| Q40851169 | Calcium-dependent and oncogenic IL-3 mRNA stabilization can be distinguished pharmacologically and by sequence requirements in the 3'UTR. |
| Q33559591 | Cardiomyopathy associated with high-dose interleukin-2 therapy |
| Q45236181 | Changes in immune cell distribution and IL-10 production are regulated through endometrial IP-10 expression in the goat uterus |
| Q77910609 | Changes with age in the modulation of natural killer activity of murine leukocytes by gastrin-releasing peptide, neuropeptide Y and sulfated cholecystokinin octapeptide |
| Q79329740 | Clinical relapses of multiple sclerosis are associated with 'novel' valleys in natural killer cell functional activity |
| Q37697703 | Cross-linking Fc receptors stimulate splenic non-B, non-T cells to secrete interleukin 4 and other lymphokines |
| Q68499138 | Differential augmentation of in vivo natural killer cytotoxicity in normal primates with recombinant human interleukin-1 and granulocyte-macrophage colony-stimulating factor |
| Q60489627 | Differential regulation of interleukin-1 gene expression in human CD3− large granular lymphocytes |
| Q70152269 | Differentiation of macrophage precursors to cells with LAK activity under the influence of CSF-1 and high dose IL-2 |
| Q35557759 | Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production. |
| Q40271897 | Early Immune Responses to Marek's Disease Vaccines |
| Q54334203 | Early expression of interferon-gamma inducible protein 10 and monokine induced by interferon-gamma in cardiac allografts is mediated by CD8+ T cells. |
| Q50437841 | Echinacea-Based Dietary Supplement Does Not Increase Maximal Aerobic Capacity in Endurance-Trained Men and Women |
| Q88295593 | Effect of internal contamination with tritiated water on the neoplastic colonies in the lungs, innate anti-tumour reactions, cytokine profile, and haematopoietic system in radioresistant and radiosensitive mice |
| Q41609469 | Effect of pharmacological purging on natural killer cell number and activity in human bone marrow. |
| Q72866067 | Effect of phototherapy and urocanic acid isomers on natural killer cell function |
| Q64100339 | Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review |
| Q27027082 | Effector mechanisms of rejection |
| Q41889708 | Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex |
| Q67547465 | Evidence for the expression of granulocyte-macrophage colony-stimulating factor receptors by human first trimester extravillous trophoblast and its response to this cytokine |
| Q77601856 | Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells |
| Q41363717 | Failure to detect interleukin (IL)-3 mRNA or protein in human keratinocytes: antibodies to granulocyte macrophage-colony-stimulating factor or IL-6 (but not IL-3) neutralize "IL-3" bioactivity |
| Q74543736 | Fc receptors on natural killer cells |
| Q52129115 | Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? |
| Q40902733 | Flow cytometric visualisation of cytokine production by CD3-CD56+ NK cells and CD3+CD56+ NK-T cells in whole blood |
| Q33747251 | Functional CD32 molecules on human NK cells |
| Q57671110 | Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin‐2, interleukin‐7 and interleukin‐12 |
| Q73223148 | Granulocyte colony-stimulating factor production by adult T-cell leukaemia cells |
| Q73924775 | Hemorheological changes and overproduction of cytokines from immune cells in mild to moderate dementia of the Alzheimer's type: adverse effects on cerebromicrovascular system |
| Q35664711 | Human NK cells in health and disease: clinical, functional, phenotypic and DNA genotypic characteristics |
| Q40047510 | IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells |
| Q28508887 | IL-21 induces the functional maturation of murine NK cells |
| Q36356764 | Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes |
| Q34476426 | IgE receptor-positive non-B/non-T cells dominate the production of interleukin 4 and interleukin 6 in immunized mice |
| Q52286491 | Immune effects of nickel. |
| Q77950065 | Immunomodulation by colony-stimulating factors |
| Q40681687 | Immunoregulatory effects of cytokines on natural killer cells |
| Q71625494 | In vitro effects of etoposide purging on natural killer cells |
| Q61911225 | In vitro generation of cytotoxic effectors activated by interleukin 2 (IL-2): comparison of autologous peripheral blood stem cells (PBSC) from adults and children |
| Q36350708 | In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment |
| Q44732419 | Induction of TNF-α production by metal complexes of γ-globulin fraction proteins and copper and zinc cations |
| Q41725881 | Induction of interleukin-3 by interleukin-1 in the absence of other exogenous stimuli |
| Q89495092 | Innate Lymphoid Cells in Colorectal Cancers: A Double-Edged Sword |
| Q70117776 | Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantation |
| Q40424145 | Interleukin-2 in Bone Marrow Transplantation |
| Q55240180 | Involvement of granulocyte colony-stimulating factor in proliferation of adult T-cell leukemia cells. |
| Q38112542 | Lineage of bone marrow-derived cells in atherosclerosis |
| Q36235358 | Lymphocyte adhesion-dependent calcium signaling in human endothelial cells |
| Q37764419 | Lymphokine-activated killer cells, natural killer cells and cytokines |
| Q68186882 | Macrophage colony-stimulating factor activity in malignant pleural effusions. Its augmentation by intrapleural interleukin-2 infusions |
| Q43992410 | Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity |
| Q70552382 | Mechanisms of allogeneic stimulation induced tumor necrosis factor-alpha (TNF-alpha) production |
| Q40064112 | Memory of Natural Killer Cells: A New Chance against Mycobacterium tuberculosis? |
| Q24311434 | Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter |
| Q36229805 | Molecular cloning of gp42, a cell-surface molecule that is selectively induced on rat natural killer cells by interleukin 2: glycolipid membrane anchoring and capacity for transmembrane signaling |
| Q41704810 | Monoclonal IgGs from an autoimmune MRL/Mp-lpr/lpr mouse induce an interleukin-3-dependent myeloid cell line to produce tumor necrosis factor alpha and interleukin-6. |
| Q46149201 | Monoclonal antibody gene transfer. Implications for tumor-specific cell-mediated cytotoxicity |
| Q44138225 | Morphological, phenotypic and functional characteristics of a pure population of CD56+ CD16- CD3- large granular lymphocytes generated from human duodenal mucosa |
| Q73193481 | Multiple color immunofluorescence for cytokine detection at the single-cell level |
| Q90229650 | NK Cell Hyporesponsiveness: More Is Not Always Better |
| Q77346789 | NK cell colony formation from human fetal thymocytes |
| Q89876422 | NK cell-derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS |
| Q57042273 | NK cell-mediated lysis of autologous human oligodendrocytes |
| Q37088602 | NK cells and their receptors |
| Q36401340 | Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells |
| Q36010408 | Natural killer activating receptors trigger interferon gamma secretion from T cells and natural killer cells |
| Q35035726 | Natural killer cell activation receptors in innate immunity to infection |
| Q36028989 | Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives |
| Q90743450 | Natural killer cells in sepsis: Underprivileged innate immune cells |
| Q73671098 | Overproduction of IFN-gamma and TNF-alpha from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer's disease |
| Q74754659 | Peripheral immature CD2-/low T cell development from type 2 to type 1 cytokine production |
| Q36361708 | Physical and functional association of p56lck with Fc gamma RIIIA (CD16) in natural killer cells |
| Q67896264 | Production of granulocyte colony-stimulating factor at the materno-foetal interface in human pregnancy |
| Q40151083 | Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF. |
| Q34225129 | Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor |
| Q41872476 | Production of the growth factors GM-CSF, G-CSF, and VEGF by human peripheral blood cells induced with metal complexes of human serum γ -globulin formed with copper or zinc ions. |
| Q78197149 | Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia |
| Q43759571 | Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus |
| Q40407042 | Regulation of granulocyte-macrophage colony-stimulating factor and interleukin 3 expression |
| Q33747309 | Regulation of human NK-cell cytokine and chemokine production by target cell recognition. |
| Q40926887 | Relationships between B cell cytokine production in secondary lymphoid follicles and apoptosis of germinal center B lymphocytes |
| Q36365733 | Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration |
| Q40381629 | Role of human natural killer cells in health and disease. |
| Q43779182 | Secretion of granulocyte-macrophage colony-stimulating factor by human blood monocytes is stimulated by engagement of Fc gamma receptors type I by solid-phase immunoglobulins requiring high-affinity Fc-Fc gamma receptor type I interactions |
| Q72848904 | Sensitivity of myeloid progenitors to NK-cell depletion |
| Q43562658 | Signaling through CD38 induces NK cell activation |
| Q72370367 | Stimulated natural killer cells secrete factors with chemotactic activity, including NAP-1/IL-8, which supports VLA-4- and VLA-5-mediated migration of T lymphocytes |
| Q37638179 | The natural killer cell: a further innate mediator of gouty inflammation? |
| Q33870557 | The origin and functions of natural killer cells |
| Q33781851 | The relative role of lymphocyte granule exocytosis versus death receptor-mediated cytotoxicity in viral pathophysiology |
| Q40540042 | The role of natural killer cells in host-parasite interactions |
| Q38679232 | The role of natural killer cells in human disease |
| Q89965828 | Thinking Outside the Box: Innate- and B Cell-Memory Responses as Novel Protective Mechanisms Against Tuberculosis |
| Q96428553 | Tissue-Resident NK Cells: Development, Maturation, and Clinical Relevance |
| Q38367784 | Treatment with granulocyte colony-stimulating factor in patients with repetitive implantation failures and/or recurrent spontaneous abortions |
| Q93046413 | Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures |
| Q38037567 | Why clinicians should be interested in interleukin-3. |
Search more.